Modulating Myeloid Derived Suppressor Cells
Our inventors have proposed a targeted delivery of miRNA nanoparticles to MDSCs to redirect differentiation and alter immunity from ‘suppressor’ to ‘responder’ mode. This novel approach may be harnessed to develop novel therapeutics for chronic lung inflammation in the elderly.
US 9,550,992 issued 2017-01-24 [MORE INFO
Type of Offer:
« More Genetics Patents« More Biology Patents